|
Mar 26
|
Viking Therapeutics Posts Promising Early Weight-Loss Data as Cost Worries Escalate
|
|
Mar 26
|
Novo Nordisk (NVO) to Buy Cardior to Boost Heart Disease Pipeline
|
|
Mar 26
|
Novo Nordisk and Nvidia Just Partnered on AI. Is the Stock a Buy?
|
|
Mar 26
|
Best Obesity Drug Stock: Eli Lilly, Novo Nordisk, or Viking Therapeutics?
|
|
Mar 26
|
32 Countries with the Highest Rates of Diabetes
|
|
Mar 25
|
Why the Market Dipped But Novo Nordisk (NVO) Gained Today
|
|
Feb 28
|
Weight loss drugs: Why state health providers should cover them
|
|
Feb 28
|
M&A on the horizon? Viking Therapeutics extends rally
|
|
Feb 28
|
EXCLUSIVE: Vivani Medical Says Weight Loss/Diabetes Implant At Par With Novo Nordisk's Famed Injectable Wegovy/Ozempic, Animal Studies Shows
|
|
Feb 28
|
Here's Why Novo Nordisk (NVO) is a Strong Momentum Stock
|
|
Feb 28
|
Stocks To Buy And Watch: Top IPOs, Big And Small Caps, Growth Stocks
|
|
Feb 28
|
This Warren Buffett Stock Is On The Cusp Of Joining The $1 Trillion Club
|
|
Feb 27
|
Why Novo Nordisk and Eli Lilly Stocks Slipped Today
|
|
Feb 27
|
Stock Splits: Should You Buy?
|
|
Feb 27
|
Drugs like Ozempic and Wegovy could boost the US economy by a trillion dollars in a few years, Goldman Sachs predicts
|
|
Feb 27
|
Novo Nordisk faces competition close to home as Danish rival Zealand Pharma’s shares jump 35% on ‘groundbreaking’ weight-loss drug trial results
|
|
Feb 27
|
Denmark, home to Ozempic-maker Novo Nordisk, is now Europe’s third-most prosperous economy
|
|
Feb 26
|
25 Countries with Highest Tax to GDP Ratio in the World
|
|
Feb 26
|
Should You Continue to Add Novo Nordisk A/S (NVO) to Your Portfolio?
|
|
Feb 24
|
1 Wall Street Analyst Thinks Novo Nordisk Stock Is Going to $140. Is It a Buy?
|